Tempus has acquired Paige, a digital pathology firm with one of the largest annotated pathology slide datasets globally, for $81.3 million in stock and assumed cloud contract commitments. This strategic move bolsters Tempus’ AI-powered oncology diagnostics, adding nearly seven million pathology slides including clinical and molecular annotations. Paige’s FDA-cleared AI applications for cancer detection will fuel Tempus’ precision medicine initiatives, accelerating cancer diagnosis and treatment decision-making globally.